Home > Back to Publisher > Report Information

Rapid Viral Testing

Drug and Market Development Publishing
April 1, 2005
105 Pages - SKU: DSMD1096856

Abstract Table of Contents Search inside this report Related Reports

Receive a thorough overview of the evolving field of rapid viral testing with D&MD’s Rapid Viral Testing Report, including market forecasts through 2010. This Report will provide the most up-to-date survey of rapid viral testing technologies and products that are available, illustrated with recent case studies and providing analyses of savings and medical as well as logistical benefits.

Chapter 1: Executive Summary
Chapter 2: The Rationale of Rapid Infectious Disease Testing: What Does “Rapid” Mean in Infectious Disease Testing?; When “Rapid” Means “Rapid and Easy:” Testing Outside the Laboratory; Home Testing and Home Collection/Mail-In Tests; Where Time Savings Can Make a Therapeutic Difference; Regulatory Considerations for Rapid Viral Testing; Privacy Issues
Chapter 3: Current and Emerging Rapid Testing Technologies: Testing Matrices; Rapid Serological Tests; Immunochromatography: The Lateral Flow Principle; Flow-Through Devices; Solid Phase Devices; CANARY: An Example for an Unconventional Antigen Detection Principle; Nucleic Acid Based Tests; The Polymerase Chain Reaction (PCR) and its Derivative Technologies; TaqMan and Modifications; Loop-Mediated Isothermal (LAMP) Assay; Conjugated Peptide Nucleic Acid (PNA) Tests; Rapid Electron Microscopy
Chapter 4: The Testing Targets and the Tests: HIV Detection and Typing; FDA-Approved HIV Antibody Tests; OraQuick Rapid HIV-1/2 Test; Reveal Rapid HIV Antibody Test; Multi-Spot HIV-1/HIV-2 Test; Uni-Gold Recombigen HIV Test; HIV Rapid Genotyping: Monitoring Drug Resistance; Hepatitis Viruses; Microarrays-Not yet a Factor in Hepatitis B Rapid Typing; HCV Genotyping; Combined HIV and HCV Infection-A Mounting Challenge; Febrile Respiratory Infections: Leading Killers Worldwide; Severe Acute Respiratory Syndrome (SARS); Respiratory Syncytial Virus (RSV); Enteroviruses; West Nile Virus; Viral Hemorrhagic Fevers; Herpes Simplex Viruses; Infectious Mononucleosis; Smallpox-The Most Significant Viral Bioterrorism Agent; Rabies; Prion Diseases
Chapter 5: Markets and Market Dynamics for Rapid Viral Tests: HIV and HCV Diagnostics-Driven by Both Point of Care and Molecular Tests; The Fluctuating Rapid Test Market for Respiratory Diseases; Viral Hemorrhagic Fevers and West Nile Virus-Another Significant Potential for Rapid Tests; International Developments; A Paradigm Change is Imminent During 2005-2010; Summary
Chapter 6: Developers and Vendors: Selected Corporate Profiles: Acon Laboratories; Artus GmbH; Bio-Rad Laboratories; Becton Dickinson Diagnostic Systems; Calypte Biomedical Corp.; Genelabs Diagnostics Pte Ltd; Inverness Medical Innovations, Inc.; Medical Services International, Inc.; MedMira Laboratories, Inc.; OraSure Technologies, Inc.; Saliva Diagnostic Systems, Inc.
LIST OF EXHIBITS: Exhibit 3.1 Lateral Flow Device Scheme; Exhibit 3.2 Flow-Through Device Scheme.; Exhibit 3.3 CANARY™ Biosensor Detection of Viral Pathogens.; Exhibit 3.4 The Principle of the Polymerase Chain Reaction (PCR); Exhibit 3.5 The TaqMan Principle; Exhibit 4.1 FDA-Approved Rapid HIV Test Kits; Exhibit 4.2 Performance Characteristics of FDA-Approved Rapid HIV Tests Compared to a Typical FDA-Approved Immunoassay under Various Conditions of HIV Prevalence; Exhibit 4.3 The OraQuick Test; Exhibit 4.4 The BioRad Multi-Spot Rapid HIV-1/HIV-2 Test; Exhibit 4.5 The Trinity Biotech Uni-Gold Recombigen HIV Assay; Exhibit 4.6 Selected Internationally Available Rapid HIV Antibody Tests without FDA Approval; Exhibit 4.7 Typical Serological Time Profile in Uncomplicated Hepatitis B; Exhibit 4.8 Selected Internationally Available Rapid Hepatitis B Tests; Exhibit 4.9 Transmission Routes for Hepatitis C Virus; Exhibit 4.10 Estimated and Acute Cases of HCV Infection, USA 1982-2001; Exhibit 4.11 Selected Internationally Available Rapid Hepatitis C Tests; Exhibit 4.12 Performance Characteristics of Rapid Influenza Assays available in the United States (as per manufacturer data); Exhibit 4.13 Distribution of Dengue Fever, 2000; Exhibit 4.14 Sequence-Predicted (left row) versus Actual (right row) Patterns of Microchip-Based Hybridization of Amplified Orthopox Virus Nucleic Acids using Fluorescence Detection

Rapid Viral Testing

Share this report

Other tasks

Research Assistance

Related Markets

Research & Development Reports

Free Alert Me service